Correlation Between INmune Bio and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Effector Therapeutics, you can compare the effects of market volatilities on INmune Bio and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Effector Therapeutics.
Diversification Opportunities for INmune Bio and Effector Therapeutics
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between INmune and Effector is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of INmune Bio i.e., INmune Bio and Effector Therapeutics go up and down completely randomly.
Pair Corralation between INmune Bio and Effector Therapeutics
If you would invest 530.00 in INmune Bio on November 4, 2024 and sell it today you would earn a total of 392.00 from holding INmune Bio or generate 73.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 5.0% |
| Values | Daily Returns |
INmune Bio vs. Effector Therapeutics
Performance |
| Timeline |
| INmune Bio |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
INmune Bio and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with INmune Bio and Effector Therapeutics
The main advantage of trading using opposite INmune Bio and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma | INmune Bio vs. Anixa Biosciences |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |